Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Oncotarget
|
February 1, 2018
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
Carlos Murga-Zamalloa, Avery Polk, Walter Hanel, et al.
Hematological Oncology
|
May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients
Kaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 4, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate
Zachary J Arnold, Jordan Lundberg, Tracy Wiczer, et al.
Cell Reports
|
December 21, 2022
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis
Vijaya Bharti, Reese Watkins, Amrendra Kumar, et al.
Cancer Medicine
|
January 19, 2023
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, et al.
Experimental Hematology & Oncology
|
September 22, 2023
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
Wing Keung Chan, Jessica Williams, Kinnari Sorathia, et al.
Blood Advances
|
February 26, 2025
Targeting the DNA damage response through TBL1X in mantle cell lymphoma
Betsy Pray, Ethan James Baiocchi, Sydney Leon, et al.
Blood Advances
|
October 4, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Kaitlin Annunzio, Natalie S Grover, Rina Li Welkie, et al.
Leukemia
|
August 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, et al.
British Journal of Haematology
|
July 1, 2025
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma
John Sharp, Qiuhong Zhao, Timothy J Voorhees, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Oncotarget
|
February 1, 2018
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
Carlos Murga-Zamalloa, Avery Polk, Walter Hanel, et al.
Hematological Oncology
|
May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients
Kaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 4, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate
Zachary J Arnold, Jordan Lundberg, Tracy Wiczer, et al.
Cell Reports
|
December 21, 2022
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis
Vijaya Bharti, Reese Watkins, Amrendra Kumar, et al.
Cancer Medicine
|
January 19, 2023
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, et al.
Experimental Hematology & Oncology
|
September 22, 2023
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
Wing Keung Chan, Jessica Williams, Kinnari Sorathia, et al.
Blood Advances
|
February 26, 2025
Targeting the DNA damage response through TBL1X in mantle cell lymphoma
Betsy Pray, Ethan James Baiocchi, Sydney Leon, et al.
Blood Advances
|
October 4, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Kaitlin Annunzio, Natalie S Grover, Rina Li Welkie, et al.
Leukemia
|
August 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, et al.
British Journal of Haematology
|
July 1, 2025
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma
John Sharp, Qiuhong Zhao, Timothy J Voorhees, et al.
Page
of 5